ES2064310T3 - Procedimiento para preparar compuestos de imidazopiridina. - Google Patents

Procedimiento para preparar compuestos de imidazopiridina.

Info

Publication number
ES2064310T3
ES2064310T3 ES87117018T ES87117018T ES2064310T3 ES 2064310 T3 ES2064310 T3 ES 2064310T3 ES 87117018 T ES87117018 T ES 87117018T ES 87117018 T ES87117018 T ES 87117018T ES 2064310 T3 ES2064310 T3 ES 2064310T3
Authority
ES
Spain
Prior art keywords
amino
protected
short
aquile
protegido
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87117018T
Other languages
English (en)
Inventor
Youichi Shiokawa
Masanobu Nagano
Hiromichi Itani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868628262A external-priority patent/GB8628262D0/en
Priority claimed from GB878723439A external-priority patent/GB8723439D0/en
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2064310T3 publication Critical patent/ES2064310T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/73—Unsubstituted amino or imino radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

LA INVENCION SE REFIERE A UN COMPUESTO DE FORMULA (I), EN LA QUE R1 ES ALQUINILO, ALQUINILOXIALQUILO O N, N''-DIALQUILAMINOALQUINILO, TODOS ELLOS DE CADENAS CORTAS; R2 ES ALQUILO DE CADENA CORTA; R3 ES ARILALQUILO SUSTITUIDO POR UNO O MAS SUSTITUYENTES SELECCIONADOS DE ENTRE LOS GRUPOS CIANO, TRIHALOALQUILO, CARBAMOILO, AMINO-PROTEGIDO, CARBOXI, CARBOXI-PROTEGIDO, HIDROXI, HIDROXI-PROTEGIDO, HIDROXIALQUILO, HIDROXIALQUILO-PROTEGIDO, AMINOALQUILPROTEGIDO O ARILALQUILO SUSTITUIDO CON ALQUILO DE CADENA CORTA, Y UN SUSTITUYENTE ADICIONAL SELECCIONADO ENTRE LOS GRUPOS HIDROXIALQUILO, AMINO, N-ALQUIL-AMINO PROTEGIDO, AMINO-PROTEGIDO Y ALQUILAMINO; Y R4 ES HIDROGENO O ALQUILO DE CADENA CORTA. TAMBIEN SE REFIERE LA INVENCION A UNA SAL FARMACEUTICAMENTE ACEPTABLE DEL COMPUESTO (I), A PROCEDIMIENTOS PARA SU PREPARACION Y A COMPOSICIONES FARMACEUTICAS QUE LO CONTIENEN, ASI COMO A PRODUCTOS INTERMEDIOS DE FORMULAS (II9 Y (III).
ES87117018T 1986-11-26 1987-11-18 Procedimiento para preparar compuestos de imidazopiridina. Expired - Lifetime ES2064310T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868628262A GB8628262D0 (en) 1986-11-26 1986-11-26 Imidazopyridine compounds
GB878723439A GB8723439D0 (en) 1987-10-06 1987-10-06 Imidazopyridine compounds

Publications (1)

Publication Number Publication Date
ES2064310T3 true ES2064310T3 (es) 1995-02-01

Family

ID=26291587

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87117018T Expired - Lifetime ES2064310T3 (es) 1986-11-26 1987-11-18 Procedimiento para preparar compuestos de imidazopiridina.

Country Status (13)

Country Link
US (1) US4831041A (es)
EP (1) EP0268989B1 (es)
KR (1) KR880006237A (es)
CN (1) CN87108027A (es)
AU (1) AU8169387A (es)
DE (1) DE3780263T2 (es)
DK (1) DK608887A (es)
ES (1) ES2064310T3 (es)
FI (1) FI875157A (es)
GR (1) GR3005685T3 (es)
HU (1) HUT45526A (es)
IL (1) IL84522A0 (es)
NO (1) NO874904L (es)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4725601A (en) * 1985-06-04 1988-02-16 Fujisawa Pharmaceutical Co., Ltd. Certain imidazo[1,2-a]pyridines useful in the treatment of ulcers
US4791117A (en) * 1986-09-22 1988-12-13 Ortho Pharmaceutical Corporation 2- or 3-aryl substituted imidazo[1,2-a]pyridines and their use as calcium channel blockers
DE3855692D1 (de) * 1987-07-16 1997-01-16 Byk Gulden Lomberg Chem Fab Imidazo[1,2-a]pyridine
GB8722488D0 (en) * 1987-09-24 1987-10-28 Fujisawa Pharmaceutical Co Imidazopyridine compound
DE69108138T2 (de) * 1990-07-30 1995-07-06 Takeda Chemical Industries Ltd Imidazopyridinderivate und ihre Verwendung.
MY110439A (en) * 1991-02-07 1998-05-30 Ishihara Sangyo Kaisha N-phenylcarbamate compound, process for preparing the same and biocidal composition for control of harmful organisms
GB9201693D0 (en) * 1992-01-27 1992-03-11 Smithkline Beecham Intercredit Compounds
US5574042A (en) * 1992-11-02 1996-11-12 Fujisawa Pharmaceutical Co., Ltd Imidazo [1,2-a] pyridines and their pharmaceutical use
IL108520A (en) * 1993-02-15 1997-09-30 Byk Gulden Lomberg Chem Fab 2, 3, 8-TRISUBSTITUTED IMIDAZO £1, 2-a| PYRIDINE DERIVATIVES, PROCESSES FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
UA48122C2 (uk) * 1993-10-11 2002-08-15 Бік Гульден Ломберг Хеміше Фабрік Гмбх АЛКОКСІАЛКІЛКАРБАМАТИ ІМІДАЗО[1,2-а]ПІРИДИНІВ, СПОСІБ ЇХ ОДЕРЖАННЯ ТА ЛІКАРСЬКИЙ ЗАСІБ НА ЇХ ОСНОВІ
NZ290818A (en) * 1994-07-28 1998-10-28 Byk Gulden Lomberg Chem Fab Benzyl-imidazopyridines
CA2196075A1 (en) * 1994-07-28 1996-02-08 Gerhard Grundler Halogenated imidazopyridines
WO1996003405A1 (de) * 1994-07-28 1996-02-08 Byk Gulden Lomberg Chemische Fabrik Gmbh Imidazopyridin-azolidinone
ATE294802T1 (de) * 1996-01-26 2005-05-15 Altana Pharma Ag 3-alkylimidazopyridine
AU1545297A (en) * 1996-01-26 1997-08-20 Byk Gulden Imidazopyridine halides
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
DE10145457A1 (de) 2001-09-14 2003-04-03 Basf Ag Substituierte Imidazo[1,2-a]-5,6,7,8-tetrahydropyridin-8-one, Verfahren zu ihrer Herstellung, sowie deren Verwendung zur Herstellung von Imidazo[1,2,-a]pyridinen
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
PT1606261E (pt) 2003-03-10 2010-01-11 Nycomed Gmbh Novo processo para a preparação de roflumilast
EP1861074B1 (en) * 2005-03-16 2013-04-24 Takeda GmbH Taste masked dosage form containing roflumilast
EP2797597B1 (en) 2011-12-28 2020-02-26 Global Blood Therapeutics, Inc. Substituted heteroaryl aldehyde compounds and methods for their use in increasing tissue oxygenation
ES2643403T3 (es) 2011-12-28 2017-11-22 Global Blood Therapeutics, Inc. Compuestos de benzaldehído sustituidos y métodos para su uso en el aumento de la oxigenación tisular
US10266551B2 (en) 2013-03-15 2019-04-23 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US10100043B2 (en) 2013-03-15 2018-10-16 Global Blood Therapeutics, Inc. Substituted aldehyde compounds and methods for their use in increasing tissue oxygenation
US8952171B2 (en) 2013-03-15 2015-02-10 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US20140274961A1 (en) 2013-03-15 2014-09-18 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
KR102293060B1 (ko) 2013-03-15 2021-08-23 글로벌 블러드 테라퓨틱스, 인크. 헤모글로빈 조정을 위한 화합물 및 이의 용도
KR20150132146A (ko) 2013-03-15 2015-11-25 글로벌 블러드 테라퓨틱스, 인크. 헤모글로빈 조정을 위한 화합물 및 이의 용도
US9422279B2 (en) 2013-03-15 2016-08-23 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US9458139B2 (en) 2013-03-15 2016-10-04 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
EP2970196B1 (en) 2013-03-15 2020-11-25 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US9802900B2 (en) 2013-03-15 2017-10-31 Global Blood Therapeutics, Inc. Bicyclic heteroaryl compounds and uses thereof for the modulation of hemoglobin
EA201992707A1 (ru) 2013-11-18 2020-06-30 Глобал Блад Терапьютикс, Инк. Соединения и их применения для модуляции гемоглобина
CN114213390A (zh) 2014-02-07 2022-03-22 全球血液疗法股份有限公司 一种化合物的结晶多晶型物
MA41841A (fr) 2015-03-30 2018-02-06 Global Blood Therapeutics Inc Composés aldéhyde pour le traitement de la fibrose pulmonaire, de l'hypoxie, et de maladies auto-immunes et des tissus conjonctifs
MA43373A (fr) 2015-12-04 2018-10-10 Global Blood Therapeutics Inc Régimes posologiques pour 2-hydroxy-6-((2- (1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)méthoxy)benzaldéhyde
TWI825524B (zh) 2016-05-12 2023-12-11 美商全球血液治療公司 用於合成2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)-吡啶-3-基)甲氧基)苯甲醛之方法
TWI778983B (zh) 2016-10-12 2022-10-01 美商全球血液治療公司 包含2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)吡啶-3-基)甲氧基)-苯甲醛之片劑
EP3860975B1 (en) 2018-10-01 2023-10-18 Global Blood Therapeutics, Inc. Modulators of hemoglobin for the treatment of sickle cell disease

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA81219B (en) * 1980-01-23 1982-01-27 Schering Corp Imidazo (1,2-a) pyridines ,process for their preparation and pharmaceutical compositions containing them
EP0068378B1 (en) * 1981-06-26 1986-03-05 Schering Corporation Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them
US4725601A (en) * 1985-06-04 1988-02-16 Fujisawa Pharmaceutical Co., Ltd. Certain imidazo[1,2-a]pyridines useful in the treatment of ulcers
EP0228006A1 (en) * 1985-12-16 1987-07-08 Fujisawa Pharmaceutical Co., Ltd. Imidazopyridine compounds and processes for preparation thereof

Also Published As

Publication number Publication date
NO874904D0 (no) 1987-11-25
CN87108027A (zh) 1988-06-08
IL84522A0 (en) 1988-04-29
KR880006237A (ko) 1988-07-22
DK608887A (da) 1988-05-27
EP0268989A1 (en) 1988-06-01
DE3780263T2 (de) 1992-12-24
DE3780263D1 (de) 1992-08-13
DK608887D0 (da) 1987-11-19
FI875157A (fi) 1988-05-27
US4831041A (en) 1989-05-16
EP0268989B1 (en) 1992-07-08
GR3005685T3 (es) 1993-06-07
NO874904L (no) 1988-05-27
FI875157A0 (fi) 1987-11-23
AU8169387A (en) 1988-06-02
HUT45526A (en) 1988-07-28

Similar Documents

Publication Publication Date Title
ES2064310T3 (es) Procedimiento para preparar compuestos de imidazopiridina.
ES2067456T3 (es) Nuevos derivados de aminoacidos, procedimientos para su preparacion y composicion farmaceutica que los comprende.
ES2094721T3 (es) Analogos de la camptotecina solubles en agua.
ES2039278T3 (es) Procedimiento para preparar inhibidores de 5-alfa-reductasa de esteroides.
IL72120A0 (en) 2-pyrimidinyl-1-piperazine derivatives,their preparation and pharmaceutical compositions containing them
EA200101203A1 (ru) Производные пурина
DE3169160D1 (en) Amino-acids derivatives and their therapeutic use
PE20040479A1 (es) Inhibidores de proteasa del vih y composiciones que los contienen
ZA919181B (en) Oxazolopyridine derivatives,processes for preparing these and pharmaceutical compositions containing them
ES2061462T3 (es) Compuestos cefemo, procedimientos para su preparacion y composiciones farmaceuticas que los contienen.
MX9305379A (es) Nuevos derivados de aminoacidos, procedimiento para su preparacion y preparado farmaceutico que los contiene.
ES8500229A1 (es) Procedimiento para preparar derivados de aminoacidos triciclicos
ES2058527T3 (es) Derivados de pirimidina condensados procedimiento y compuestos intermedios para su preparacion y composiciones farmaceuticas que los contienen.
ES2127919T3 (es) 4-amino-piridinas, procedimiento para su preparacion, asi como medicamentos que contienen estos compuestos.
MY103850A (en) Phenol substituted gem-diphosphonate derivatives, process for their preparation and pharmaceutical compositions containing them.
DK159777C (da) N-alkyl-norscopiner og fremgangsmaade til fremstilling heraf samt deres anvendelse som mellemprodukter
ES2038630T3 (es) Un procedimiento para preparar un compuesto de acido fenoxiacetico.
GR71207B (es)
ES2188743T3 (es) Compuestos de acido pirrolidinilhidroxamico y procedimiento de produccion de los mismos.
HUT53664A (en) Process for producing enzyme inhibiting amino acid derivatives and pharmaceutical compositions comprising such compounds as active ingredient
ES2148458T3 (es) Derivados de fenil-4-tiazoles sustituidos, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
ES8401064A1 (es) Procedimiento para la obtencion de azolil-fenoxi-tetrahidrofuran-2-iliden-metanos.
NO821841L (no) Mettede aminocyklitderivater, deres fremstilling og legemiddel inneholdende dem
DE3062340D1 (en) 1-n-alkylsisomicin derivatives, process for their preparation and their use as medicines
ES2054729T3 (es) Derivados de pirrolidina.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 268989

Country of ref document: ES